Supercharge Bioavailability
Micellar Technology
Award winning, AquaCelle® is a customisable, self micro-emulsifying delivery system (SMEDS). Specifically designed and clinically proven to optimise the bioavailability of oily lipophilic active ingredients such as, ubiquinol, omega-3s, lutein and resveratrol whilst maintaining product stability.
Clinically shown to improve bioavailability by up to 700%.
Optimised for Functionality
Combine supercharged bioavailability with format functionality, an AquaCelle® enhanced oily active ingredient can easily be transformed into a solid free flowing powder when loaded onto CPO® technology.
AquaCelle® Advantages:
optimised biovailablity
increased functionality
innovative dosage formats
reduced dose size
highly customisable
clinically validated with human pharmacokinetic studies
improved stability, overcomes associated risks and overages
reduces unwanted reflux from omega-3 actives
polysorbate free
the use of pharmacopoeial grade ingredients
patented technology
Australian developed and made
Published Studies
AquaCelle® CoQ10 impacts on micelle size & increases ubiquinone absorption
The novel delivery system AquaCelle® demonstrated superior supply of ubiquinone (Q10) when compared with a standard ubiquinone extract.
AquaCelle® Omega-3 improves EPA and DHA bioavailability
The study assessed the ability of a self-emulsifying drug delivery system (SEDDS), AquaCelle®, as an additive to enhance the oral absorption of Omega-3 ethyl esters (EE) in healthy subjects under low-fat diet conditions.
Awards and Grants
NSW Department of Industry Tech Connections voucher granted for AquaCelle® Omega Study
Ingredient of the Year Healthy Ageing AquaCelle® Q10
AquaCelle® is a patented technology, and a trademark owned exclusively by Pharmako Biotechnologies Pty. Ltd., registered in Australia and other countries.